Shopping Cart 0
Cart Subtotal
USD 0

Inova Health System - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 750

Details

Summary

Inova Health System (Inova) is a non-profit health care delivery system. It owns owns, operates and manages several research, educational, clinical and hospital facilities. It offers home health and long term care services, joint replacement services, liver disease services, mental health services, and neurosciences services among others. Through a network of hospitals including Inova Alexandria Hospital, Inova Fair Oaks Hospital, Inova Fairfax Hospital, Inova Loudoun Hospital, and Inova Mount Vernon Hospital the organization provides inpatient services and outpatient health services including emergency and urgent care, senior services, home care, mental health and blood donor services. Its other healthcare facilities include Inova Heart and Vascular Institute (IHVI), Inova Translational Medicine Institute (ITMI) which focuses on genomics research, Inova Neuroscience Institute and Inova Children's Hospital. Inova is headquartered in Falls Church, Virginia, the US.

Inova Health System-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Inova Health System, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Inova Health System, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Inova Health System, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Inova Health System, Medical Devices Deals, 2012 to YTD 2018 9

Inova Health System, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Inova Health System, Pharmaceuticals & Healthcare, Deal Details 11

Partnerships 11

Inova Health System Enters into Research Agreement with George Mason University 11

Debt Offering 12

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2027 For USD 1.7 Million 12

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2040 For USD 85.1 Million 13

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2020 For USD 3.3 Million 14

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2019 For USD 3.4 Million 15

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2026 For USD 1.9 Million 16

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2037 For USD 35 Million 17

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2013 For USD 4.1 Million 18

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2025 For USD 2.6 Million 19

Inova Health System Completes Public Offering Of Series 2012B Bonds Due 2022 For USD 2 Million 20

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2021 For USD 3.3 Million 21

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2016 For USD 4.4 Million 22

Inova Health System Completes Public Offering Of Series 2012B Bonds Due 2022 For USD 33 Million 23

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2023 For USD 2.9 Million 24

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2015 For USD 4.3 Million 25

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2017 For USD 4.5 Million 26

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2024 For USD 2.7 Million 27

Inova Health System Completes Public Offering Of Series 2012B Bonds Due 2022 For USD 25 Million 28

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2032 For USD 5.2 Million 29

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2018 For USD 3.4 Million 30

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2022 For USD 3.3 Million 31

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2014 For USD 4 Million 32

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2035 For USD 15 Million 33

Acquisition 34

Inova Health Completes Acquisition Of Amerigroup Virginia, Healthcare Company 34

Inova Health System-Key Competitors 35

Inova Health System-Key Employees 36

Inova Health System-Locations And Subsidiaries 37

Head Office 37

Other Locations & Subsidiaries 37

Recent Developments 39

Corporate Communications 39

Mar 14, 2018: Inova Board Names J. Stephen Jones as New Chief Executive Officer 39

Oct 18, 2017: The Society for Women's Health Research Elects Roberta L. Gartside, MD, as Incoming Chair of Its Board of Directors 40

Sep 15, 2017: Inova CEO Knox Singleton Announces Retirement 41

Sep 06, 2017: Inova Names Mickey Y. Kim, MD, MBA, Senior Vice President of Research and Commercialization 42

Government and Public Interest 43

May 18, 2018: President George W. Bush Headlines Record-Breaking Fundraiser for Inova Schar Cancer Institute 43

Other Significant Developments 44

Feb 23, 2018: Inova Loudoun Hospital Mobile Health Services March 2018 Screenings Schedule 44

Feb 19, 2018: Inova Loudoun Hospital Offering New Hope And Insights 45

Appendix 46

Methodology 46

About GlobalData 46

Contact Us 46

Disclaimer 46


List Of Figure

List of Figures

Inova Health System, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Inova Health System, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Inova Health System, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Inova Health System, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Inova Health System, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Inova Health System, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Inova Health System, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Inova Health System, Pharmaceuticals & Healthcare, Key Facts 2

Inova Health System, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2

Inova Health System, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Inova Health System, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Inova Health System, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Inova Health System, Medical Devices Deals, 2012 to YTD 2018 9

Inova Health System, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Inova Health System Enters into Research Agreement with George Mason University 11

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2027 For USD 1.7 Million 12

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2040 For USD 85.1 Million 13

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2020 For USD 3.3 Million 14

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2019 For USD 3.4 Million 15

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2026 For USD 1.9 Million 16

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2037 For USD 35 Million 17

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2013 For USD 4.1 Million 18

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2025 For USD 2.6 Million 19

Inova Health System Completes Public Offering Of Series 2012B Bonds Due 2022 For USD 2 Million 20

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2021 For USD 3.3 Million 21

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2016 For USD 4.4 Million 22

Inova Health System Completes Public Offering Of Series 2012B Bonds Due 2022 For USD 33 Million 23

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2023 For USD 2.9 Million 24

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2015 For USD 4.3 Million 25

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2017 For USD 4.5 Million 26

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2024 For USD 2.7 Million 27

Inova Health System Completes Public Offering Of Series 2012B Bonds Due 2022 For USD 25 Million 28

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2032 For USD 5.2 Million 29

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2018 For USD 3.4 Million 30

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2022 For USD 3.3 Million 31

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2014 For USD 4 Million 32

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2035 For USD 15 Million 33

Inova Health Completes Acquisition Of Amerigroup Virginia, Healthcare Company 34

Inova Health System, Key Competitors 35

Inova Health System, Key Employees 36

Inova Health System, Other Locations 37

Inova Health System, Subsidiaries 38

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Company Profile

Company Profile Title

Summary

Inova Health System (Inova) is a non-profit health care delivery system. It owns owns, operates and manages several research, educational, clinical and hospital facilities. It offers home health and long term care services, joint replacement services, liver disease services, mental health services, and neurosciences services among others. Through a network of hospitals including Inova Alexandria Hospital, Inova Fair Oaks Hospital, Inova Fairfax Hospital, Inova Loudoun Hospital, and Inova Mount Vernon Hospital the organization provides inpatient services and outpatient health services including emergency and urgent care, senior services, home care, mental health and blood donor services. Its other healthcare facilities include Inova Heart and Vascular Institute (IHVI), Inova Translational Medicine Institute (ITMI) which focuses on genomics research, Inova Neuroscience Institute and Inova Children's Hospital. Inova is headquartered in Falls Church, Virginia, the US.

Inova Health System-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Inova Health System, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Inova Health System, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Inova Health System, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Inova Health System, Medical Devices Deals, 2012 to YTD 2018 9

Inova Health System, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Inova Health System, Pharmaceuticals & Healthcare, Deal Details 11

Partnerships 11

Inova Health System Enters into Research Agreement with George Mason University 11

Debt Offering 12

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2027 For USD 1.7 Million 12

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2040 For USD 85.1 Million 13

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2020 For USD 3.3 Million 14

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2019 For USD 3.4 Million 15

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2026 For USD 1.9 Million 16

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2037 For USD 35 Million 17

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2013 For USD 4.1 Million 18

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2025 For USD 2.6 Million 19

Inova Health System Completes Public Offering Of Series 2012B Bonds Due 2022 For USD 2 Million 20

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2021 For USD 3.3 Million 21

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2016 For USD 4.4 Million 22

Inova Health System Completes Public Offering Of Series 2012B Bonds Due 2022 For USD 33 Million 23

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2023 For USD 2.9 Million 24

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2015 For USD 4.3 Million 25

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2017 For USD 4.5 Million 26

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2024 For USD 2.7 Million 27

Inova Health System Completes Public Offering Of Series 2012B Bonds Due 2022 For USD 25 Million 28

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2032 For USD 5.2 Million 29

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2018 For USD 3.4 Million 30

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2022 For USD 3.3 Million 31

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2014 For USD 4 Million 32

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2035 For USD 15 Million 33

Acquisition 34

Inova Health Completes Acquisition Of Amerigroup Virginia, Healthcare Company 34

Inova Health System-Key Competitors 35

Inova Health System-Key Employees 36

Inova Health System-Locations And Subsidiaries 37

Head Office 37

Other Locations & Subsidiaries 37

Recent Developments 39

Corporate Communications 39

Mar 14, 2018: Inova Board Names J. Stephen Jones as New Chief Executive Officer 39

Oct 18, 2017: The Society for Women's Health Research Elects Roberta L. Gartside, MD, as Incoming Chair of Its Board of Directors 40

Sep 15, 2017: Inova CEO Knox Singleton Announces Retirement 41

Sep 06, 2017: Inova Names Mickey Y. Kim, MD, MBA, Senior Vice President of Research and Commercialization 42

Government and Public Interest 43

May 18, 2018: President George W. Bush Headlines Record-Breaking Fundraiser for Inova Schar Cancer Institute 43

Other Significant Developments 44

Feb 23, 2018: Inova Loudoun Hospital Mobile Health Services March 2018 Screenings Schedule 44

Feb 19, 2018: Inova Loudoun Hospital Offering New Hope And Insights 45

Appendix 46

Methodology 46

About GlobalData 46

Contact Us 46

Disclaimer 46


List Of Figure

List of Figures

Inova Health System, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Inova Health System, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Inova Health System, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Inova Health System, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Inova Health System, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Inova Health System, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Inova Health System, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Inova Health System, Pharmaceuticals & Healthcare, Key Facts 2

Inova Health System, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2

Inova Health System, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Inova Health System, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Inova Health System, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Inova Health System, Medical Devices Deals, 2012 to YTD 2018 9

Inova Health System, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Inova Health System Enters into Research Agreement with George Mason University 11

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2027 For USD 1.7 Million 12

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2040 For USD 85.1 Million 13

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2020 For USD 3.3 Million 14

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2019 For USD 3.4 Million 15

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2026 For USD 1.9 Million 16

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2037 For USD 35 Million 17

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2013 For USD 4.1 Million 18

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2025 For USD 2.6 Million 19

Inova Health System Completes Public Offering Of Series 2012B Bonds Due 2022 For USD 2 Million 20

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2021 For USD 3.3 Million 21

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2016 For USD 4.4 Million 22

Inova Health System Completes Public Offering Of Series 2012B Bonds Due 2022 For USD 33 Million 23

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2023 For USD 2.9 Million 24

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2015 For USD 4.3 Million 25

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2017 For USD 4.5 Million 26

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2024 For USD 2.7 Million 27

Inova Health System Completes Public Offering Of Series 2012B Bonds Due 2022 For USD 25 Million 28

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2032 For USD 5.2 Million 29

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2018 For USD 3.4 Million 30

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2022 For USD 3.3 Million 31

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2014 For USD 4 Million 32

Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2035 For USD 15 Million 33

Inova Health Completes Acquisition Of Amerigroup Virginia, Healthcare Company 34

Inova Health System, Key Competitors 35

Inova Health System, Key Employees 36

Inova Health System, Other Locations 37

Inova Health System, Subsidiaries 38

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS